Investigation into the Anticancer Activity and Apoptosis Induction of Brevinin-2R and Brevinin-2R-Conjugated PLA–PEG–PLA Nanoparticles and Strong Cell Cycle Arrest in AGS, HepG2 and KYSE-30 Cell Lines
- 16 Downloads
Our study aims to establish a biocompatible nanostructure for the improved delivery of anticancer peptide, Brevinin-2R, to treat human gastric adenocarcinoma (AGS), human liver hepatocellular carcinoma (HepG2) and human squamous cell carcinoma (KYSE-30) cells. Poly(l-lactide)–poly(ethylene glycol)–poly(l-lactide) (PLA–PEG–PLA) nanoparticles were synthesized, obtained by a solvent evaporation method and characterized using scanning electron microscopy (SEM), FTIR and DLS; chemically-synthesized Brevinin-2R was encapsulated in micelles. In vitro release and cell uptake assay were conducted before cytotoxicity tests. Cell cycle analysis and apoptosis study were performed through flow cytometry and Annexin-V-FlOUS cell staining. PLA–PEG–PLA nanoparticles showed a narrow-size distribution with a zeta potential of − 26.63 and a high cell internalization. Brevinin-2R-conjugated nanoparticles were spherical in shape with an increased surface charge of − 21.90. For the first time, viability tests showed that Brevinin-2R-conjugated nanoparticles were more efficient than Brevinin-2R against cancer cells causing higher rates of cell cycle arrest and apoptosis induction. Our new findings demonstrate the potential of PLA–PEG–PLA nanoparticles to boost the anticancer effect and improve the delivery of Brevinin-2R. The study of Brevinin-2R-loaded nanoparticles indicated noticeable results in terms of novel cancer therapy. PLA–PEG–PLA nanoparticles can act as a biocompatible delivery platform to take the advantage of Brevinin-2R toward cancer cells. This is a novel study as the Brevinin-2R-conjugated nanoparticles and applied approaches have not been already reported.
KeywordsApoptosis induction Brevinin-2R-conjugated nanoparticle Cell cycle arrest Cell internalization Drug loading Enhanced anticancer efficiency
This research was financially supported by the University of Mohaghegh Ardabili, Ardabil, Iran. The authors would like to acknowledge Jennifer Mason for proofreading the article. We are also grateful to the contribution of Dr. Hossein Akbari from Ardabil Azad University and Mehdi Hassanvand Jamadi from University of Shahid Beheshti to statistical analysis and critical reviewing of manuscript.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Research Involving Human and Animal Participants
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW (2018) ECCO essential requirements for quality cancer care: oesophageal and gastric cancer. Crit Rev Oncol Hematol 122:179–193. https://doi.org/10.1016/j.critrevonc.2017.12.019 CrossRefPubMedPubMedCentralGoogle Scholar
- Amaral AC, Silva ON, Mundim NC, de Carvalho MJ, Migliolo L, Leite JR, Prates MV, Bocca AL, Franco OL, Felipe MS (2012) Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics. Peptides 37:301–308. https://doi.org/10.1016/j.peptides.2012.07.021 CrossRefPubMedPubMedCentralGoogle Scholar
- Asadi H, Rostamizadeh K, Salari D, Hamidi M (2011) Preparation of biodegradable nanoparticles of tri-block PLA–PEG–PLA copolymer and determination of factors controlling the particle size using artificial neural network. J Microencapsul 28:406–416. https://doi.org/10.3109/02652048.2011.576784 CrossRefPubMedPubMedCentralGoogle Scholar
- Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC (2009) PLGA lecithin–PEG core shell nanoparticles for controlled drug delivery. Biomaterials 30:1627–1634. https://doi.org/10.1016/j.biomaterials.2008.12.013 CrossRefPubMedPubMedCentralGoogle Scholar
- Davies EA, Bevis HE, Delves-Broughton J (1997) The use of the bacteriocin, nisin, as a preservative in ricotta type cheeses to control the food-borne pathogen Listeria monocytogenes. Lett Appl Microbiol 24(5):343–346. https://doi.org/10.1046/j.1472-765X.1997.00145.x CrossRefPubMedPubMedCentralGoogle Scholar
- Dell’Erba R, Groeninckx G, Maglio G, Malinconico M, Migliozzi A (2001) Immiscible polymer blends of semicrystalline biocompatible components: thermal properties and phase morphology analysis of PLLA/PCL blends. Polymer 42:7831–7840. https://doi.org/10.1016/S0032-3861(01)00269-5 CrossRefGoogle Scholar
- Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M (2008) Brevinin-2R1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med 12:1005–1022. https://doi.org/10.1111/j.1582-4934.2008.00129.x CrossRefGoogle Scholar
- Homayouni-Tabrizi M, Asoodeh A, Soltani M, Forghanifard MM (2015) Antimicrobial peptide Brevinin-2R induces the secretion of a pro-inflammatory cytokine in HepG2 cells. J Basic Res Med Sci 2:23–29Google Scholar
- Jelonek K, Li S, Kaczmarczyk B, Marcinkowski A, Orchel A, Musiał-Kulik M, Kasperczyk J (2016) Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs—the influence of drug-drug and drug polymer interactions on drug loading and release properties. Int J Pharm 510:365–374. https://doi.org/10.1016/j.ijpharm.2016.06.051 CrossRefPubMedPubMedCentralGoogle Scholar
- Kakde D, Jain D, Shrivastava V, Kakde R, Patil AT (2011) Cancer therapeutics-opportunities, challenges and advances in drug delivery. J Appl Pharm Sci 1:1–10Google Scholar
- Mehrnejad F, Naderi-Manesh H, Ranjbar B, Maroufi B, Asoodeh A, Doustdar F (2008) PCR-based gene synthesis, molecular cloning, high level expression, purification, and characterization of novel antimicrobial peptide, brevinin-2R, in Escherichia coli. Appl Biochem Biotechnol 149:109–118. https://doi.org/10.1007/s12010-007-8024-z CrossRefGoogle Scholar
- Middleton DR, Bouaoun L, Hanisch R, Bray F, Dzamalala C, Chasimpha S, Menya D, Mbalawa CG, N’Da G, Woldegeorgis MA, Njie R (2018) Esophageal cancer male to female incidence ratios in Africa: a systematic review and meta-analysis of geographic, time and age trends. Cancer Epidemiol 53:119–128. https://doi.org/10.1016/j.canep.2018.01.020 CrossRefPubMedPubMedCentralGoogle Scholar
- Woraphatphadung T, Sajomsang W, Rojanarata T, Ngawhirunpat T, Tonglairoum P, Opanasopit P (2018) Development of chitosan-based pH-sensitive polymeric micelles containing curcumin for colon targeted drug delivery. AAPS PharmSciTech 19:991–1000. https://doi.org/10.1208/s12249-017-0906-y CrossRefPubMedPubMedCentralGoogle Scholar
- Zohri M, Alavidjeh MS, Haririan I, Ardestani MS, Ebrahimi SE, Sani HT, Sadjadi SK (2010) A comparative study between the antibacterial effect of nisin and nisin-loaded chitosan/alginate nanoparticles on the growth of Staphylococcus aureus in raw and pasteurized milk samples. Probiotics Antimicrob Proteins 2(4):258–266. https://doi.org/10.1007/s12602-010-9047-2 CrossRefPubMedPubMedCentralGoogle Scholar